Jeff Jerman

1.0k total citations
12 papers, 789 citations indexed

About

Jeff Jerman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jeff Jerman has authored 12 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jeff Jerman's work include Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (3 papers) and Ion channel regulation and function (2 papers). Jeff Jerman is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (3 papers) and Ion channel regulation and function (2 papers). Jeff Jerman collaborates with scholars based in United Kingdom, Germany and Belgium. Jeff Jerman's co-authors include Darren Smart, Christopher D. Benham, Jean Prenen, John B. Davis, Joris Vriens, Guy Droogmans, Bernd Nilius, Veit Flockerzi, Hiroyuki Watanabe and G. David Smith and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jeff Jerman

12 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Jerman United Kingdom	10	437	285	162	161	142	12	789
Yungang Lu United States	17	185 0.4×	180 0.6×	156 1.0×	155 1.0×	118 0.8×	27	693
Takayoshi Masuoka Japan	16	126 0.3×	245 0.9×	39 0.2×	224 1.4×	114 0.8×	49	685
Katharine L. Chu United States	20	449 1.0×	349 1.2×	94 0.6×	319 2.0×	647 4.6×	28	1.2k
Elfrida R. Grant United States	13	228 0.5×	361 1.3×	25 0.2×	422 2.6×	198 1.4×	13	854
Una Park United States	5	480 1.1×	489 1.7×	32 0.2×	295 1.8×	184 1.3×	6	1.1k
Minghua Li United States	18	75 0.2×	527 1.8×	105 0.6×	512 3.2×	235 1.7×	34	1.1k
S. A. Prestwich United Kingdom	17	236 0.5×	652 2.3×	59 0.4×	505 3.1×	153 1.1×	23	1.0k
Ian McFadzean United Kingdom	19	306 0.7×	845 3.0×	64 0.4×	532 3.3×	346 2.4×	32	1.2k

Countries citing papers authored by Jeff Jerman

Since Specialization

Citations

This map shows the geographic impact of Jeff Jerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Jerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Jerman more than expected).

Fields of papers citing papers by Jeff Jerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Jerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Jerman. The network helps show where Jeff Jerman may publish in the future.

Co-authorship network of co-authors of Jeff Jerman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Jerman. A scholar is included among the top collaborators of Jeff Jerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Jerman. Jeff Jerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Jerman, Jeff, et al.. (2022). Investigating the potential of GalR2 as a drug target for neuropathic pain. Neuropeptides. 98. 102311–102311. 3 indexed citations

Cook, Jennifer M., et al.. (2022). Identification of a novel specific small-molecule melanocortin-2-receptor antagonist. Endocrine Connections. 11(12). 4 indexed citations

Wright, Paul D., et al.. (2019). Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2. Biochemical and Biophysical Research Communications. 520(1). 35–40. 16 indexed citations

Clark, Adrian, et al.. (2016). ACTH Antagonists. Frontiers in Endocrinology. 7. 101–101. 34 indexed citations

Rocheville, Magalie, Julio Martín, Jeff Jerman, & Evi Kostenis. (2013). Mining the Potential of Label-Free Biosensors for Seven-Transmembrane Receptor Drug Discovery. Progress in molecular biology and translational science. 115. 123–142. 18 indexed citations

Wright, Paul D., et al.. (2013). Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK. Biochemical and Biophysical Research Communications. 441(2). 463–468. 32 indexed citations

Mackenzie, Amanda E., C. Southern, Jeff Jerman, et al.. (2012). High-Throughput Identification and Characterization of Novel, Species-selective GPR35 Agonists. Journal of Pharmacology and Experimental Therapeutics. 344(3). 568–578. 34 indexed citations

Rocheville, Magalie & Jeff Jerman. (2009). 7TM pharmacology measured by label-free: a holistic approach to cell signalling. Current Opinion in Pharmacology. 9(5). 643–649. 27 indexed citations

Soffin, Ellen M., Catherine H. Gill, Stephen Brough, Jeff Jerman, & Ceri H. Davies. (2004). Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 46(8). 1168–1176. 42 indexed citations

10.

Watanabe, Hiroyuki, John B. Davis, Darren Smart, et al.. (2002). Activation of TRPV4 Channels (hVRL-2/mTRP12) by Phorbol Derivatives. Journal of Biological Chemistry. 277(16). 13569–13577. 490 indexed citations

11.

Duxon, Mark, Kathryn R. Starr, Declan N.C. Jones, et al.. (2001). Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement. Psychopharmacology. 153(2). 203–209. 79 indexed citations

12.

Herdon, Hugh J., Jeff Jerman, Tania O. Stean, et al.. (1996). The novel anticonvulsant SB 204269 binds to a stereospecific site in the mouse brain. European Journal of Pharmacology. 314(3). R7–R8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yungang Lu Breakdown of academic impact, for papers by Takayoshi Masuoka Breakdown of academic impact, for papers by Katharine L. Chu Breakdown of academic impact, for papers by Elfrida R. Grant Breakdown of academic impact, for papers by Una Park Breakdown of academic impact, for papers by Minghua Li Breakdown of academic impact, for papers by S. A. Prestwich Breakdown of academic impact, for papers by Ian McFadzean